CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles.

Autor: Terrones, Marc1,2 (AUTHOR), Deben, Christophe2 (AUTHOR), Rodrigues-Fortes, Felicia2 (AUTHOR), Schepers, Anne1,2 (AUTHOR), de Beeck, Ken Op1,2 (AUTHOR), Van Camp, Guy1,2 (AUTHOR), Vandeweyer, Geert1 (AUTHOR) geert.vandeweyer@uantwerpen.be
Zdroj: Journal of Translational Medicine. 3/3/2024, Vol. 22 Issue 1, p1-16. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje